Fulcrum Therapeutics (FULC)
(Delayed Data from NSDQ)
$3.87 USD
+0.27 (7.50%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $3.88 +0.01 (0.26%) 7:58 PM ET
1-Strong Buy of 5 1
C Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | 0.87 |
Last EPS Surprise | 1,550.00% |
ABR | 2.63 |
Earnings ESP
|
-4.13% |
---|---|
Current Year | -0.28 |
Next Year | -1.14 |
EPS (TTM) | -0.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 80.00M | NA |
# of Estimates | NA | NA | 4 | NA |
High Estimate | NA | NA | 80.00M | NA |
Low Estimate | NA | NA | 80.00M | NA |
Year ago Sales | 0.76M | 0.87M | 2.81M | 80.00M |
Year over Year Growth Est. | NA | NA | 2,752.05% | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.32 | -0.28 | -1.14 |
# of Estimates | 6 | 5 | 5 | 6 |
Most Recent Consensus | NA | -0.22 | -0.15 | -0.66 |
High Estimate | -0.37 | -0.22 | -0.15 | -0.66 |
Low Estimate | -0.44 | -0.44 | -0.39 | -1.91 |
Year ago EPS | -0.39 | -0.40 | -1.59 | -0.28 |
Year over Year Growth Est. | -2.56% | 20.00% | 82.39% | -308.32% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 5 | 5 | 5 |
Up Last 60 Days | 1 | 5 | 5 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.40 | -0.32 | -0.28 | -1.14 |
7 Days Ago | -0.40 | -0.32 | -0.28 | -1.14 |
30 Days Ago | -0.41 | -0.43 | -0.46 | -1.51 |
60 Days Ago | -0.42 | -0.43 | -0.46 | -1.67 |
90 Days Ago | -0.45 | -0.46 | -1.33 | -1.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.42 | -0.32 | -0.28 | -1.14 |
Zacks Consensus Estimate | -0.40 | -0.32 | -0.28 | -1.14 |
Earnings ESP | -4.13% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.87 | -0.43 | -0.40 | -0.39 | NA |
Estimate | -0.06 | -0.44 | -0.44 | -0.44 | NA |
Difference | 0.93 | 0.01 | 0.04 | 0.05 | 0.26 |
Surprise | 1,550.00% | 2.27% | 9.09% | 11.36% | 393.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more